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What’s Next for Obamacare?
Peter Hilsenrath, University of the Pacific and Liam O’Neill,
University of North Texas Health Science Center
The surprising and transformational national election of 2016 has
left many wondering what is to become of President Obama’s
signature healthcare reform. Republicans mounted sustained and
energetic resistance since its inception. But now, they have
responsibility for what comes next. The US healthcare system is
widely recognized as both inequitable and inefficient. Obama and
the Democrats opted to prioritize the former with the Medicaid
expansion and the health insurance exchanges. Over 20 million
more Americans are now insured, an achievement Democrats wish
to preserve. In addition, almost three million young Americans
under 26 are now covered by their parents’ plan. Republicans will
not simply end these programs with a return to the 2009 status
quo. More likely, Medicaid expansion will be reformed, perhaps
with risk adjusted per capita allocations or block grants as well as
loosening of state implementation oversight. Funds may be
distributed more evenly across the states including to those that
previously opted out, such as Texas and Florida. Coverage may
become less generous. Blue states with large enrollment gains thus
far stand to lose the most with reduced federal subsidies. This
seems unlikely to disturb Republicans very much. Health
insurance exchanges are already reeling in many states from poor
design. A death spiral of adverse selection has set in with
enrollment of high utilization beneficiaries, rising costs and ever
higher premiums that serve to dissuade relatively healthy
members from remaining. This drives averages costs and
premiums even higher. Inadequate penalties for those who choose
not to sign up through the health exchanges are part of the
problem but these are more likely to be eliminated than sharply
increased. According to the IRS, about 7.5 million Americans paid

an average fine of $200 for not having health insurance in 2014.
Republicans will probably give insurers a freer hand to set
premiums based on expected cost. This will allow for more
attractive premiums for the relatively healthy. Those with chronic
or pre-existing conditions may be directed to assigned risk pools.
Health savings accounts are likely to be coupled with high
deductible policies. These tax advantaged instruments will be
more beneficial to those with higher incomes. Insurer
consolidation across state lines can also be expected. Out-of-state
insurers will find formation of new provider networks difficult but
acquisition of existing ones may be attractive.
Obamacare offers less to improve efficiency. But the high
deductible nature of the exchanges should be welcomed by
Republicans as a form of consumer-driven health care. Many of
the innovations in delivery such as Accountable Care
Organizations that incentivize integration and cost savings will
likely survive and further develop. Other measures such as a
powerful federal organization called the Medicare Independent
Payment Advisory Board, though never formed, is sure to be
stricken from the books. The Cadillac Tax which imposes a 40
percent surcharge on rich plans above a threshold and not slated
to take effect until 2020 will also be a target. It is not popular and
has already been postponed for two years. On the other hand,
economists are generally of one mind that tax preferences for
health insurance leads to over-insurance and excessive healthcare
expenditures. Republicans may opt to repeal the tax but tinker
with the exclusion of employer-provided health insurance as
taxable compensation.
These and other measures will alter the course of health sector
development but the landmark nature of Obama’s achievement
will endure. On the other hand, the greater issue of displacement
of much of the economy by low productivity health services will
continue to confound politicians loath to provide leadership about

what is not worth paying for. An inefficient health sector will still
sap the growth potential of an already anemic economy. Further
leadership on the issue remains salient for future elections.

